• 제목/요약/키워드: interferon-gamma ($IFN-{\gamma}$)

검색결과 340건 처리시간 0.026초

Synergistic Effect of Lipopolysaccharide and Interferon-$\beta$ on the Expression of Chemokine Mig mRNA

  • Lee, Moon-Sook;Kim, Sung-Kwang;Kim, Hee-Sun
    • Journal of Microbiology and Biotechnology
    • /
    • 제12권5호
    • /
    • pp.813-818
    • /
    • 2002
  • Expression of monokine induced by IFN-$\gamma$(Mig) mRNA is well-known to strictly depend on Interferon-$\gamma$(IFN-$\gamma$). Lipopolysaccharide (LPS) alone Is weakly effective on Mig mRNA expression in mouse Peritoneal macrophages. This study was undertaken to investigate the synergistic effect of LPS and IFN-$\beta$ on chemokine Mig gene expression in mouse peritoneal macrophages. Although IFN-$\beta$ alone was minimally effective, LPS plus IFN-$\beta$ synergized to produce a high level of Mig mRNh. The synergistic effect of LPS and IFN-$\beta$ (LPS/IFN-$\beta$) on Mig mRNA expression was strain-specific. The most effective synergistic effect of LPS/IFN-$\beta$ on the mRNh expression was found in simultaneous stimulation of LPS/IFN-$\beta$. This synergy was modulated at the level of the gene transcription and was not dependent on a new protein synthesis. Synergistic effect of LPS/IFN-$\beta$ also required the activation of $NF-_KB$. Accordingly, these data suggest that LPS/IFN-$\beta$ synergizes the expression of Mig mRNA through a process that depends on a pretranscriptional level and/or coincident Mig mRNA transcription.

Effects of Oral Administration of Phellinus linteus on the Productions of the Th1- and Th2-type Cytokines in Mice

  • Oh, Gi-Su;Pae, Hyun-Ock;Choi, Byung-Min;Kwon, Ji-Wung;Yun, Yeong-Ho;Choi, Jeong-Ho;Kwon, Tae-Oh;Park, Young-Chul;Chung, Hun-Teag
    • IMMUNE NETWORK
    • /
    • 제3권3호
    • /
    • pp.182-187
    • /
    • 2003
  • Background: The mushroom Phellinus linteus (PL) has been shown to have the anti-tumor and immunostimulatory effects. We hypothesized that the hot water extract of PL (WEPL) exerts its significant immunostimulatory effect by inducing production of the Th1-derived cytokine interferon-${\gamma}$ (IFN-${\gamma}$) by T lymphocytes. Methods: T lymphocytes were isolated from the mice fed with 200 mg/kg of WEPL once a day for 4 weeks, and then stimulated with the mitogen concanavaline A (Con A). IFN-${\gamma}$ gene and intracellular protein expressions were analyzed by RT-PCR and flow cytometry, respectively. The production of IFN-${\gamma}$ was measured by enzyme-linked immunosorbent assay. Results: WEPL significantly enhanced the transcription of IFN-${\gamma}$ mRNA. The effect of WEPL on IFN-${\gamma}$ expression was further supported by a concomitant increase in the number of cells with intracellular IFN-${\gamma}$ protein as well as the secretion of IFN-${\gamma}$. However, WEPL did not modulate either gene expression or protein secretion of interleukin-4, a Th2-associated cytokine, by Con A-stimulated T lymphocytes. Conclusion: Our results demonstrate that one of the potentially beneficial anti-tumor and immunostimulatory effects of WEPL may be mediated through the enhancement of IFN-${\gamma}$ secretion by T lymphocytes.

The Changes of P-glycoprotein Activity by Interferon-γ and Tumor Necrosis Factor-α in Primary and Immortalized Human Brain Microvascular Endothelial Cells

  • Lee, Na-Young;Rieckmann, Peter;Kang, Young-Sook
    • Biomolecules & Therapeutics
    • /
    • 제20권3호
    • /
    • pp.293-298
    • /
    • 2012
  • The purpose of this study was to investigate the modification of expression and functionality of the drug transporter P-glycoprotein (P-gp) by tumor necrosis factor-alpha (TNF-${\alpha}$) and interferon-gamma (IFN-${\gamma}$) at the blood-brain barrier (BBB). We used immortalized human brain microvessel endothelial cells (iHBMEC) and primary human brain microvessel endothelial cells (pHBMEC) as in vitro BBB model. To investigate the change of p-gp expression, we carried out real time PCR analysis and Western blotting. To test the change of p-gp activity, we performed rhodamin123 (Rh123) accumulation study in the cells. In results of real time PCR analysis, the P-gp mRNA expression was increased by TNF-${\alpha}$ or IFN-${\gamma}$ treatment for 24 hr in both cell types. However, 48 hr treatment of TNF-${\alpha}$ or IFN-${\gamma}$ did not affect P-gp mRNA expression. In addition, co-treatment of TNF-${\alpha}$ and IFN-${\gamma}$ markedly increased the P-gp mRNA expression in both cells. TNF-${\alpha}$ or IFN-${\gamma}$ did not influence P-gp protein expression whatever the concentration of cytokines or duration of treatment in both cells. However, P-gp expression was increased after treatments of both cytokines together in iHBMEC cells only compared with untreated control. Furthermore, in both cell lines, TNF-${\alpha}$ or IFN-${\gamma}$ induced significant decrease of P-gp activity for 24 hr treatment. And, both cytokines combination treatment also decreased significantly P-gp activity. These results suggest that P-gp expression and function at the BBB is modulated by TNF-${\alpha}$ or/and IFN-${\gamma}$. Therefore, the distribution of P-gp depending drugs in the central nervous system can be modulated by neurological inflammatory diseases.

Lipopolysaccharide Synergizes with Interferon-${\gamma}$ to Induce Expression of Mig mRNA in Mouse Peritoneal Macrophages

  • Kim, Young-Ho;Kim, Hee-Sun
    • Journal of Microbiology and Biotechnology
    • /
    • 제10권5호
    • /
    • pp.599-605
    • /
    • 2000
  • Lipopolysaccharide (LPS) is responsible for the tissue injury that occurs following the invasion of multicelluar organisms by Gram-negative microbes. The effect of LPS on IFN-$\gamma$-induced chemokine Mig gene expression in mouse peritoneal macrophages was investigated. Very little Mig mRNA was detectable upon exposure to LPS without IFN-$\gamma$. Although LPS alone is only minimally effective, LPS plus IFN-$\gamma$ synergized to produce a high level of Mig mRNA in the peritoneal macrophages. This synergy was not dependent on a new protein synthesis, and was not controlled at the level of the gene transcription. Futhermore, LPS did not increase IFN-$\gamma$-induced Mig mRNA stability. Accordingly, it is suggested the LPS may synergize the expression of IFN-$\gamma$-induced Mig mRNA through a process that depends on a pretranscriptional level or concurrent Mig mRNA translation.

  • PDF

202종(種) 한약재(韓藥材)의 $IFN-{\gamma}$ 분비조절에 관한 비교연구 (Comparative study of 202 herbs on interferon-gamma secretion)

  • 이시형;강미숙;최유경;전찬용;박종형;김동우
    • 대한한방내과학회지
    • /
    • 제27권2호
    • /
    • pp.336-344
    • /
    • 2006
  • Objects : This study has been carried out to assess the effects of the variable herbs on $IFN-{\gamma}$ secretion in the mouse spleen cell. Methods : 202 kinds of herb extracts were used to evaluate the $IFN-{\gamma}$ secretory distinction by each $1{\mu}g/ml$ and $10{\mu}g/ml$ density of water. All experimental herbs were grouped by oriental herbalogical method. But each herb had its independent variables. Results : The secretions increased in 20% of all herbal water. The density differences also make different effects on the secretion of $IFN-{\gamma}$. The secretion of IFN-${\gamma}$ inclosed in some kinds of herbs of IFN-${\gamma}$. It has representatively increased in Imperaetae Rhizoma(白茅根) of $1{\mu}g/ml$ and Notopterygii Rhizoma(羌活)of $10{\mu}g/ml$. $IFN-{\gamma}$ incresed in 12 kinds of heybs of both densities. The secretion of $IFN-{\gamma}$ decreased in some kinds of herbs of $IFN-{\gamma}$. It has representatively decreased in Moutan Radicis Cortex(蘇丹皮) of $1{\mu}g/ml$ and Angelicae Radix(富歸尾) of $10{\mu}g/ml$. $IFN-{\gamma}$ decreased in 18 kinds of herbs of both densities. In t oriental herb group, The secretion of $IFN-{\gamma}$ increased in Bang-Hyang-Hwa-Sup group(芳香化濕藥), He-Pyo group(解表藥), I-Su-Sam-SuP group(利水渗) The secretion of $IFN-{\gamma}$ decreased in Gu-Chung group(驅蟲藥), An-Sin group(安神藥). Su-Sap group(收澁) On-Li group(溫裏藥), I-Gi group(利氣藥). Conclusions : The result of this study will not only broaden applications of oriental medicine to biological therapy, but also form the basis of oriental medical therapy to find out the meaning of oriental classification.

  • PDF

Effect of interferon-γ on the fusion of mononuclear osteoclasts into bone-resorbing osteoclasts

  • Kim, Jeung-Woo;Lee, Myeung-Su;Lee, Chang-Hoon;Kim, Ha-Young;Chae, Soo-Uk;Kwak, Han-Bok;Oh, Jae-Min
    • BMB Reports
    • /
    • 제45권5호
    • /
    • pp.281-286
    • /
    • 2012
  • Osteoclasts are multinucleated cells that are formed by the fusion of pre-fusion osteoclasts (pOCs). The fusion of pOCs is known to be important for osteoclastic bone resorption. Here, we examined the effect of IFN-${\gamma}$ on the fusion of pOCs. IFN-${\gamma}$ greatly increased the fusion of pOCs in a dose-dependent manner. Furthermore, IFN-${\gamma}$ induced pOC fusion even in hydroxyapatite-coated plates used as a substitute for bone. The resorption area of pOCs stimulated with IFN-${\gamma}$ was significantly higher than that of the control cells. IFN-${\gamma}$ induced the expression of dendritic cell-specific transmembrane protein (DC-STAMP), which is responsible for the fusion of pOCs. IFN-${\gamma}$ enhanced DC-STAMP expression in a dose-dependent manner. The mRNA expression of c-Fos and nuclear factor of activated T cells (NFAT) c1 was enhanced in the pOCs treated with IFN-${\gamma}$. Taken together, these results provide a new insight into the novel role of IFN-${\gamma}$ on the fusion of pOCs.

폐흡충 감염 마우스에 있어 비장세포에서 분비되는 $interferon-\{\gamma}$ 및 interleukin-4의 생산 (Production of $interferon-\{\gamma}$ and interleukin-4 by splenocytes in mice infected with Paragonimus westermani)

  • 신명헌;민득영
    • Parasites, Hosts and Diseases
    • /
    • 제34권3호
    • /
    • pp.185-190
    • /
    • 1996
  • 폐흡층(Paragonimus westermani) 감염시 일어나는 TH cytokin 반응을 알아보고자 마우스에 폐흡충 피낭유충을 감염시킨 후 비장세포를 Con A로 자극하여 TH1-specific cytokine인 $IFN-{\gamma}$와 TH2-specific cytokin인 IL-4의 생산량을 감염시기별로 효소표식 면역검사법으로 측정하였다. 폐흡충 감염 마우스의 비장세포에서 생산되는 IL-4는 감염 후 3일($410{\;}{\pm}{\;}60.9{\;}pg/ml$)에 최고치에 도달한 후 2주($343{\;}{\pm}{\;}59.0{\;}pg/ml$)까지 대조군에 비해 높게 유지되었으나 감염 후 4주에는 감소되기 시작하여 6주에는 대조군의 생산량과 비슷하였다. 한편 폐흡충 감염 마우스의 비장세포에서 생산되는 $IFN-{\gamma}$는 감염 후 1주($151{\;}{\pm}{\;}32.2{\;}pg/ml$)에만 대조군에 비해 높게 증가되었을 뿐 2주부터 감소되기 시작하여 감염 후 6주에는 전혀 측정되지 않아 오히려 대조군의 생산량보다도 적었다. 또한 폐흡충 감염 마우스의 혈청 내 IL-4의 양은 감염 후 4주부터 6주에 대조군에 비해 높게 증가되었으며 혈청내 $IFN-{\gamma}$의 양은 전 실험기간을 통해 측정되지 않았다. 이상의 결과를 종합할때 폐흡층 감염마우스에서는 $IFN-{\gamma}$보다는 IL-4가 증가되는 TH2 cytokine 반응이 주로 일어남을 알 수 있었다.

  • PDF

폐결핵환자의 치료 시점에 따른 말초혈액 단핵구의 IFN-$\gamma$, TNF-$\alpha$ 분비능의 변화 (Change of IFN-$\gamma$ and TNF-$\alpha$ Producing Capacity in the Course of Chemotherapy in Patients with Pulmonary Tuberculosis)

  • 임재준;이상민;이재호;유철규;이춘택;정희순;김영환;한성구;심영수
    • Tuberculosis and Respiratory Diseases
    • /
    • 제48권2호
    • /
    • pp.149-154
    • /
    • 2000
  • 배 경: 결핵에 대한 인체의 면역반응의 근간을 이루는 것은 대식세포가 결핵균을 탐식하여 사멸시키는 것이다. 이 과정에는 Interferon-gamma(IFN-$\gamma$)와 Tumor necrosis factor-alpha(TNF-$\alpha$) 가 중요한 역할을 한다. 저자들은 phytohemagglutinin(PHA) 혹은 purified protein derivative(PPD)에 의한 말초혈액 단핵구의 IFN-$\gamma$와 TNF-$\alpha$의 분비능이 폐결핵 환자들에서 치료함에 따라 어떻게 변화하는지를 살펴보고자하였다. 방 법: 폐결핵으로 확진되었고 전형적인 임상상을 보이는 치료시작 전 환자 5명, 치료시작 후 4개월이내의 환자 11명, 치료시작 후 4 개월에서 9개월 사이의 환자 6명 그리고 치료를 종료한 환자 7명을 대상으로 하였다. 환자의 말초혈액 단핵구를 분리하여 PHA와 PPD로 자극한 후 IFN-$\gamma$와 TNF-$\alpha$를 측정하여 서로 비교하였다. 결 과: 각 군간에 PHA와 PPD로 자극한 후 말초혈액 단핵구의 IFN-$\gamma$와 TNF-$\alpha$의 분비능은 차이가 없었다. 결 론: 전형적인 임상상을 보이는 폐결핵환자들에서 그 치료 시점에 따른 IFN-$\gamma$와 TNF-$\alpha$의 분비능의 차이는 없었다.

  • PDF

교반형 막 반응기를 이용한 재조합 인간 세포의 무혈청 배지에 의한 $\gamma$-Interferon의 생산 (Economic Production of $\gamma$-Interferon from Recombinant Human Cells in Serum Free Medium by a Moving Aeration Membrane Bioreactor)

  • 박영식;김현규;임서규;박경유;이현용
    • 한국미생물·생명공학회지
    • /
    • 제22권4호
    • /
    • pp.389-394
    • /
    • 1994
  • 8 X 10$^{6}$(viable cells/ml) of maximum cell density and 9000(IU/ml) of $\gamma$-IFN production were obtained at 55(ml/hr) of a perfusion rate by cultivating HSF cells using a moving membrane aeration bioreactor. This system proves to be an efficient culture process by maintaning 90% of viable cells during the whole cultivation periods. The metabolic molar quotient of glucose to lactate was 0.81 for overall ranges of glucose consumed while the evolution of ammonia was not linearly related to the consumption of glutamine. Low molar conversion ratio was observed in low consumptions of glutamine and high molar conversion ratio in high comsumptions. It also shows that the glutamolysis plays important role in the steady state conditions by evolving larger quantities of ammonia than lactate. At the above of 50 rpm, which is the optimum agitation speed for this bioreactor, the cell growth was severely affected while the IFN production was less decrea- sed, maintaing 1.5 X 10$^{-3}$(IU/cell/day) specific IFN production rate. The cumulatvie $\gamma$-IFN production was 7.2 X 10$^{8}$(IU) for 70 days of the cultivation, which yields 1 X 10$^{7}$ (IU/day) of IFN production rate. Therefore, a commercial production of $\gamma$-IFN by this culture process can be achievable by maintaining the above IFN productivity in a scaled-up culture system.

  • PDF

특발성 폐섬유화증에서 Interferon gamma-1b 치료의 단기 임상경험 (Short-term Clinical Experience on Interferon gamma-1b Therapy for Idiopathic Pulmonary Fibrosis)

  • 황정혜;정만표;강은해;김경찬;이병훈;고원중;서지영;김호중;이경수;한정호;권오정
    • Tuberculosis and Respiratory Diseases
    • /
    • 제56권6호
    • /
    • pp.619-627
    • /
    • 2004
  • 연구배경 : 특발성 폐섬유화증의 치료로서 항섬유화제제인 IFN-${\gamma}1b$로 단기간 치료 받은 환자들의 치료반응 및 부작용을 보고자 하였다. 방 법 : IFN-${\gamma}1b$ (200만 IU씩 주 3회 피하주사)로 치료받은 특발성 폐섬유화증 환자 27명을 대상으로 후향적 연구를 하였다. 이 중 6개월 이상 IFN-${\gamma}1b$ 치료를 받은 17명의 치료반응을 평가하여 cortico-steroids와 cyclophosphamide로 치료 받은 26명의 치료반응과 비교하였다. 결 과 : 1) 총 27명의 연령은 59(44-74)세 였고 남자가 19명(70%) 이었다. 2) 사망 및 진행을 보인 악화군(5명)은 안정군(12명)에 비해 치료 전 FVC(55% vs. 71%, p=0.019)와 DLco(50% vs. 77%, p=0.014)가 좋지 않았고, 치료전 동맥혈 산소분압(69mmHg vs. 91mmHg, p=0.001)도 낮았다. 3) corticosteroids와 cyclophosphamide로 치료 받은 26명과 IFN-${\gamma}1b$로 치료 받은 17명의 6개월 후 치료반응은 서로 차이가 없었다(p=0.73). 4) 부작용은 총 12명(44%)에서 발생하였고 이 중 5명은 심각한 약제 부작용으로 치료를 중단하였고 1명은 급성호흡곤란증후군으로 사망하였다. 결 론 : IFN-${\gamma}1b$의 단기간 치료는 폐기능이 좋지 않거나 진행된 상태의 특발성 폐섬유화증 환자의 치료로는 바람직하지 않으며 치명적인 부작용이 발생할 수 있으므로 조심스럽게 사용하여야 한다고 생각한다.